CS logo
small CS logo
Orszagos Onkologiai Intezet Sugarterapias Osztaly

Budapest, Hungary
Kórház, Budapest

About Orszagos Onkologiai Intezet Sugarterapias Osztaly


Az Országos Onkológiai Intézet Budapest Hegyvidékének gyógyító, kutató, oktatókórháza.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Orszagos Onkologiai Intezet Sugarterapias Osztaly


During the past decade, Orszagos Onkologiai Intezet Sugarterapias Osztaly conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Orszagos Onkologiai Intezet Sugarterapias Osztaly" #1 collaborator was "GORTEC (Head and Neck Oncology and Radiotherapy Group)" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Orszagos Onkologiai Intezet Sugarterapias Osztaly


According to Clinical.Site data, the most researched conditions in "Orszagos Onkologiai Intezet Sugarterapias Osztaly" are "Squamous Cell Carcinoma of the Head and Neck" (2 trials), "Giant Cell Glioblastoma" (1 trials), "Glioblastoma" (1 trials), "Glioblastoma With Oligodendroglial Component" (1 trials) and "Gliosarcoma" (1 trials). Many other conditions were trialed in "Orszagos Onkologiai Intezet Sugarterapias Osztaly" in a lesser frequency.

Clinical Trials Intervention Types at Orszagos Onkologiai Intezet Sugarterapias Osztaly


Most popular intervention types in "Orszagos Onkologiai Intezet Sugarterapias Osztaly" are "Drug" (3 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Avelumab" (1 trials), "Chemoradiation" (1 trials), "Cisplatin" (1 trials), "Intensity Modulation Radiation Therapy (IMRT)" (1 trials) and "KLH" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Orszagos Onkologiai Intezet Sugarterapias Osztaly


The vast majority of trials in "Orszagos Onkologiai Intezet Sugarterapias Osztaly" are 3 trials for "All" genders.

Clinical Trials Status at Orszagos Onkologiai Intezet Sugarterapias Osztaly


Currently, there are NaN active trials in "Orszagos Onkologiai Intezet Sugarterapias Osztaly". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Orszagos Onkologiai Intezet Sugarterapias Osztaly, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Orszagos Onkologiai Intezet Sugarterapias Osztaly, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".